A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

June 30, 2030

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

Sonrotoclax

Administered orally

DRUG

Zanubrutinib

Administered orally

Trial Locations (38)

8036

Hospital Clinic de Barcelona, Barcelona

25123

Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, Brescia

28027

Clinica Universidad de Navarra, Madrid

28040

Hospital Universitario Fundacion Jimenez Diaz, Madrid

31008

Clinica Universidad de Navarra Pamplona, Pamplona

33394

Hospital de Cabuenes, Gijón

41124

Universita Degli Studi Di Modena Azienda Ospedaliere Policlinco, Modena

50134

Aou Careggi, Servizio Sanitario Toscana, Florence

68198

University of Nebraska Medical Center, Omaha

84107

Utah Cancer Specialists, Salt Lake City

90146

Aoor Villa Sofia Cervello, Palermo

97401

Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene

200025

Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

210029

Jiangsu Province Hospital, Nanjing

213000

The First Peoples Hospital of Changzhou, Changzhou

310003

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

350001

Fujian Medical University Union Hospital, Fuzhou

450000

Henan Cancer Hospital, Zhengzhou

33136-2107

University of Miami, Miami

33331-3609

Cleveland Clinic Florida, Weston

30060-1152

Northwest Georgia Oncology Centers Marietta, Marietta

60714-5905

Illinois Cancer Specialists (Niles) Usor, Niles

21201-1544

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore

68130-2042

Nebraska Cancer Specialists (Satellite Site), Omaha

Nebraska Cancer Specialists, Omaha

07932-1049

Summit Medical Group, Florham Park

11967-4704

New York Cancer and Blood Specialists, Shirley

75231-7001

Texas Oncology Dfw, Dallas

75702-7522

Texas Oncology Tyler, Tyler

98684-6930

Northwest Cancer Specialist, Pc(Us Oncology Research), Vancouver

88034-000

Centro de Pesquisas Oncologicas Cepon, Florianópolis

900350-903

Hospital de Clinicas de Porto Alegre, Porto Alegre

04501-000

Instituto Dor de Pesquisa E Ensino Sao Paulo, São Paulo

05653-120

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo

40-519

Pratia Onkologia Katowice, Katowice

30-727

Pratia McM Krakow, Krakow

20-090

Uniwersytecki Szpital Kliniczny Nr W Lublinie, Lublin

50-367

Uniwersytecki Szpital Kliniczny Hematology, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeOne Medicines

INDUSTRY

NCT06637501 - A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter